Literature DB >> 12902473

Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors.

Björn Peters1, Sascha Bulik, Robert Tampe, Peter M Van Endert, Hermann-Georg Holzhütter.   

Abstract

We are able to make reliable predictions of the efficiency with which peptides of arbitrary lengths will be transported by TAP. The pressure exerted by TAP on Ag presentation thus can be assessed by checking to what extent MHC class I (MHC-I)-presented epitopes can be discriminated from random peptides on the basis of predicted TAP transport efficiencies alone. Best discriminations were obtained when N-terminally prolonged epitope precursor peptides were included and the contribution of the N-terminal residues to the score were down-weighted in comparison with the contribution of the C terminus. We provide evidence that two factors may account for this N-terminal down-weighting: 1) the uncertainty as to which precursors are used in vivo and 2) the coevolution in the C-terminal sequence specificities of TAP and other agents in the pathway, which may vary among the various MHC-I alleles. Combining predictions of MHC-I binding affinities with predictions of TAP transport efficiency led to an improved identification of epitopes, which was not the case when predictions of MHC-I binding affinities were combined with predictions of C-terminal cleavages made by the proteasome.

Mesh:

Substances:

Year:  2003        PMID: 12902473     DOI: 10.4049/jimmunol.171.4.1741

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  115 in total

1.  Discriminating self from nonself with short peptides from large proteomes.

Authors:  Nigel J Burroughs; Rob J de Boer; Can Keşmir
Journal:  Immunogenetics       Date:  2004-07-30       Impact factor: 2.846

Review 2.  MHC class II epitope predictive algorithms.

Authors:  Morten Nielsen; Ole Lund; Søren Buus; Claus Lundegaard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

Review 3.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

4.  The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund; Can Keşmir
Journal:  Immunogenetics       Date:  2005-03-03       Impact factor: 2.846

5.  Ab and T cell epitopes of influenza A virus, knowledge and opportunities.

Authors:  Huynh-Hoa Bui; Bjoern Peters; Erika Assarsson; Innocent Mbawuike; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-02       Impact factor: 11.205

Review 6.  Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource.

Authors:  Yohan Kim; Alessandro Sette; Bjoern Peters
Journal:  J Immunol Methods       Date:  2010-10-31       Impact factor: 2.303

7.  Prediction of epitopes using neural network based methods.

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  J Immunol Methods       Date:  2010-10-31       Impact factor: 2.303

8.  Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation.

Authors:  Arron Hearn; Ian A York; Courtney Bishop; Kenneth L Rock
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

9.  A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.

Authors:  Aisha N Hasan; Wouter J Kollen; Deepa Trivedi; Annamalai Selvakumar; Bo Dupont; Michel Sadelain; Richard J O'Reilly
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

10.  Human self-protein CD8+ T-cell epitopes are both positively and negatively selected.

Authors:  Michal Almani; Shai Raffaeli; Tal Vider-Shalit; Lea Tsaban; Vered Fishbain; Yoram Louzoun
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.